A detailed history of Profund Advisors LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Profund Advisors LLC holds 16,544 shares of CORT stock, worth $863,100. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,544
Previous 17,321 4.49%
Holding current value
$863,100
Previous $562,000 36.12%
% of portfolio
0.03%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$29.51 - $46.26 $22,929 - $35,944
-777 Reduced 4.49%
16,544 $765,000
Q2 2024

Aug 13, 2024

SELL
$22.21 - $34.48 $139,034 - $215,844
-6,260 Reduced 26.55%
17,321 $562,000
Q1 2024

May 08, 2024

BUY
$21.1 - $27.46 $156,709 - $203,945
7,427 Added 45.98%
23,581 $594,000
Q4 2023

Feb 14, 2024

BUY
$24.82 - $32.88 $116,579 - $154,437
4,697 Added 41.0%
16,154 $524,000
Q3 2023

Nov 13, 2023

SELL
$21.97 - $33.8 $61,340 - $94,369
-2,792 Reduced 19.59%
11,457 $312,000
Q2 2023

Aug 10, 2023

SELL
$21.44 - $25.15 $16,337 - $19,164
-762 Reduced 5.08%
14,249 $317,000
Q1 2023

May 11, 2023

BUY
$19.2 - $24.47 $50,880 - $64,845
2,650 Added 21.44%
15,011 $325,000
Q4 2022

Feb 02, 2023

SELL
$19.95 - $29.96 $11,032 - $16,567
-553 Reduced 4.28%
12,361 $251,000
Q3 2022

Nov 04, 2022

SELL
$24.7 - $29.12 $21,736 - $25,625
-880 Reduced 6.38%
12,914 $331,000
Q2 2022

Aug 01, 2022

SELL
$17.33 - $25.3 $30,500 - $44,528
-1,760 Reduced 11.32%
13,794 $328,000
Q1 2022

May 10, 2022

BUY
$16.53 - $25.21 $1,636 - $2,495
99 Added 0.64%
15,554 $350,000
Q4 2021

Feb 08, 2022

SELL
$17.1 - $23.34 $17,613 - $24,040
-1,030 Reduced 6.25%
15,455 $306,000
Q3 2021

Nov 12, 2021

SELL
$19.68 - $22.53 $47,566 - $54,455
-2,417 Reduced 12.79%
16,485 $324,000
Q2 2021

Aug 12, 2021

BUY
$19.97 - $24.43 $21,627 - $26,457
1,083 Added 6.08%
18,902 $417,000
Q1 2021

May 14, 2021

SELL
$23.49 - $30.56 $35,845 - $46,634
-1,526 Reduced 7.89%
17,819 $424,000
Q4 2020

Feb 09, 2021

BUY
$16.78 - $27.3 $62,589 - $101,829
3,730 Added 23.89%
19,345 $506,000
Q3 2020

Nov 13, 2020

SELL
$12.46 - $19.98 $15,400 - $24,695
-1,236 Reduced 7.33%
15,615 $272,000
Q2 2020

Aug 03, 2020

BUY
$11.0 - $18.26 $29,370 - $48,754
2,670 Added 18.83%
16,851 $283,000
Q1 2020

May 15, 2020

SELL
$10.11 - $14.04 $34,080 - $47,328
-3,371 Reduced 19.21%
14,181 $169,000
Q4 2019

Feb 18, 2020

BUY
$12.06 - $16.96 $13,905 - $19,554
1,153 Added 7.03%
17,552 $212,000
Q3 2019

Nov 12, 2019

SELL
$10.41 - $14.66 $16,437 - $23,148
-1,579 Reduced 8.78%
16,399 $232,000
Q2 2019

Aug 13, 2019

SELL
$9.78 - $12.76 $11,921 - $15,554
-1,219 Reduced 6.35%
17,978 $200,000
Q1 2019

May 15, 2019

SELL
$10.03 - $15.71 $97,942 - $153,408
-9,765 Reduced 33.72%
19,197 $225,000
Q4 2018

Feb 14, 2019

SELL
$11.29 - $17.19 $163,727 - $249,289
-14,502 Reduced 33.37%
28,962 $387,000
Q3 2018

Nov 13, 2018

BUY
$12.27 - $15.65 $272,982 - $348,181
22,248 Added 104.86%
43,464 $609,000
Q2 2018

Aug 13, 2018

BUY
$15.3 - $19.69 $28,840 - $37,115
1,885 Added 9.75%
21,216 $334,000
Q1 2018

May 14, 2018

BUY
$14.59 - $25.5 $74,613 - $130,407
5,114 Added 35.97%
19,331 $318,000
Q4 2017

Feb 14, 2018

BUY
$15.77 - $20.72 $224,202 - $294,576
14,217
14,217 $257,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.59B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.